Microdosing

Recently LabCorp entered into a partnership to enable users of CLEAR’s Health Pass mobile app to securely link their LabCorp test results using their LabCorp Patient™ account. The partnership brings together LabCorp’s advanced testing capabilities, including its COVID-19 tests, with CLEAR’s safe and secure Health Pass technology.  It's one of many emerging health passport solutions.

Siemens Healthineers is consistently regarded as a leader in life sciences.  A big reason for this is their thought leadership.  In this episode, we'll talk about why that is.

In 2018, JP Morgan, Berkshire Hathaway, and Amazon backed the formation of Haven Healthcare.  The headlines erupted with excitement.  Three years later, it closed its doors.  So what happened?  In this episode, I share my two cents.

Through Black History Month, the University of North Texas Health Science Center ("HSC") is hosting a variety of events not only celebrating BHM, and are actively helping to drive impact in the black community.  We'll contrast this with the routine "content chaos" that happens each holiday or national fill-in-the-blank month, where content is pushed-out without any relevance or action behind it.

With Teladoc Health's recent acquisition of Livongo, we have officially entered the era of healthcare platforms.  In this episode, we'll explore the fundamentals of a healthcare platform, and what the future holds for Teladoc Health.

We’ll take a look at Team Novo Nordisk. An all diabetic cycling team, sponsored by Novo Nordisk.

We'll look at how GE Healthcare is applying a broadcasting model to its thought leadership through its series with journalist and filmmaker, Mikey Kay. And how in many ways, the broadcast model will likely grow in importance as it relates to marketing and content in the digital age.

It's been rare that anyone has ever known the manufacturer of the vaccines they receive.  Yet, as the COVID-19 vaccines come to market, the corporate brands of those vaccines are filling the headlines.  In this episode, we explore how that impacts decision-making of doctors and patients as it relates to drug and vaccine selection the future.

In this episode, well look at the three new CEOs of the largest medical device companies who took office in 2020.